Production (Stage)
MiNK Therapeutics, Inc.
INKT
$7.26
-$0.035-0.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.74M | -10.78M | -13.78M | -17.09M | -20.59M |
| Total Depreciation and Amortization | 212.40K | 215.40K | 215.10K | 206.00K | 212.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 741.70K | 554.20K | 952.90K | 3.08M | 3.27M |
| Change in Net Operating Assets | 430.00K | 459.80K | 1.75M | 1.72M | 3.17M |
| Cash from Operations | -8.35M | -9.56M | -10.86M | -12.08M | -13.94M |
| Capital Expenditure | -- | -- | 0.00 | -23.00K | -60.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | -23.00K | -60.00K |
| Total Debt Issued | 0.00 | 5.00M | 5.00M | 5.00M | 5.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.81M | 5.82M | 5.82M | 5.82M | 31.90K |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | -97.70K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.81M | 10.82M | 10.82M | 10.82M | 4.93M |
| Foreign Exchange rate Adjustments | -41.60K | -54.60K | -26.80K | -23.60K | -10.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.58M | 1.21M | -70.50K | -1.31M | -9.07M |